Navigation Links
Patients often assume wrongly that they are allergic to penicillin

A team of researchers who reviewed medical literature on the accuracy of penicillin allergies has come out with a startling expose!!!!

Nearly 80% of people who claim that they are allergic to penicillin actually are under the misconception that they are allergic to the drug.

The researchers led by Dr. Alan R. Salkind, an associate professor of medicine at the University of Missouri-Kansas City School of Medicine, say that many patients fail to use these antibiotics because they misunderstand simple reactions to be drug allergies.

Penicillin and penicillin-like antibiotic drugs are often preferable to alternative antibiotics, Salkind noted, because they are cheaper than many other drugs and less likely to induce side effects or cause drug resistance. The best way out of this problem is to perform an on the spot skin test to check if the patient is actually hypersensitive to penicillin, the scientists say.

To reach these conclusions, the researchers conducted a review of 14 prior studies conducted in the last four decades.

They found that 80% to 90% of patients who reported they were allergic to penicillin, based on a recollected history of a reaction to the antibiotic, were incorrect when assessed by skin allergy testing.

Salkind said that only around 2% to 5% of the general population has a true allergy to penicillin. These allergic reactions, which can be measured by the presence of antibodies in the body, may cause such symptoms as breaking out in severe rashes and breathlessness.

However if a person develops rashes or an upset stomach three days after taking penicillin injections then it is very unlikely to be a drug hypersensitivity reaction. The eruptions could be due to the underlying disease itself for which penicillin was prescribed or could be because of an unrelated coincidental cause.

So the next time someone says they have penicillin allergy, make sure to do a simple skin test beca use jumping to conclusions!!
'"/>




Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. New FDA Approved Drug NATRECOR For Heart Failure Patients
7. Hemochromatosis Patients Blood is Safe
8. Patients Pressure Would Result In Overprescription
9. Risk Of Decongestants In Hypertensive Patients
10. Interference helps Heart Patients
11. Stem Cell Transplants May Be Effective For MS Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... , ... March 29, 2017 , ... During the last ... provide free screening colonoscopies to eligible individuals in the local community. , Colon ... but regular screenings can detect colon cancer while it is small, confined and easier ...
(Date:3/29/2017)... , ... March 29, 2017 , ... Full Contact K9, ... of Pet Protect Law that assists dog owners in creating legally-enforceable pet ... owners in taking the natural next step to protect their new companion. Says Evan ...
(Date:3/29/2017)... Petersburg, FL (PRWEB) , ... March 30, 2017 , ... ... called the "Spice of Life" or "Wonder Spice", it has been used for thousands ... use in the East," says Heshelow, author of " Turmeric: How to Use it ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wall Centre Dental ... new patients from Burnaby, BC. Patients in need of experienced orthodontics, laser dentistry, ... see the esteemed team at Wall Centre Dental. Drs. Parviz Roshan, Siamak Tehrani, ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... as it continues developing an ANSI-approved, consensus-based American National Standard for Good ... to publish the first ANSI-approved GMP standard for dietary supplements this spring, ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , March 29, 2017  The Global ... Japanese public-private partnership formed to battle infectious diseases ... totaling US$23 million* that could help deliver a ... of debilitating conditions. This latest ... Phase 3 clinical trial testing a pediatric formulation ...
(Date:3/29/2017)... TREE, Colo. , March 29, 2017  Zynex (OTCQB: ... manufacture and sale of non-invasive medical devices for pain ... today that it will host the Company,s 2016 full-year ... a.m. Eastern Time.) The Company expects to ... 31, 2017. ...
(Date:3/29/2017)... 29, 2017  Glenmark Pharmaceuticals, a global pharmaceutical ... an investigational fixed-dose combination of mometasone furoate (25 ... as a nasal spray being studied for the ... from a recently completed Phase 3 trial assessing ... therapy versus mometasone, olopatadine or placebo. ...
Breaking Medicine Technology: